Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
Franz‐Josef Meyer‐Almes
Topics & Concepts
Drug repositioningVirtual screeningPharmacologyDrugRepurposingIndinavirApproved drugMedicineVirologyChemistryDrug discoveryBiologyHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyBiochemistryEcologyComputational Drug Discovery MethodsSynthesis and biological activityCancer therapeutics and mechanisms